盐酸曲美他嗪片治疗冠心病不稳定性心绞痛临床分析

Clinical Analysis of Trimetazidine Dihydrochloride Tablets in the Treatment of Unstable Angina Pectoris and Coronary Heart Disease

目的分析并研究盐酸曲美他嗪片对于冠心病不稳定性心绞痛进行治疗的临床治疗效果。方法本研究所有研究对象均为我院在2015年4月—2016年7月收治的冠心病不稳定性心绞痛患者40例,采用随机方法将所有患者分为观察组和对照组,每组各有20例,对照组患者采用常规治疗方法进行治疗,观察组患者在常规治疗基础之上,为患者配合盐酸曲美他嗪片进行治疗,对两组患者的治疗效果进行比较。结果比较两组患者治疗的有效率,观察组患者的治疗有效率明显优于对照组,两组比较,P<0.05,差异有统计学意义;比较两组患者的不良反应发生情况,P>0.05,差异无统计学意义。结论临床上对于冠心病不稳定性心绞痛患者在进行治疗的时候,在常规用药基础之上为患者选择盐酸曲美他嗪片进行治疗,可有效的促进患者治疗有效率的提升。

Objective To analyze and study the clinical effect of trimetazidine dihydrochloride tablets in the treatment of unstable angina pectoris and coronary heart disease. Methods In this study, 40 cases of patients with coronary heart disease and unstable angina patients in our hospital from April 2015 to July 2016 were randomly divided into observation group and control group, each group had 20 cases, patients in the control group were treated with conventional treatment, the observation group patients were treated with trimetazidine dihydrochloride tablets on the basis of conventional treatment, and the treatment effects of the two groups were compared. Results The treatment efficiency of the two groups was compared, the treatment efficiency of the observation group was significantly better than that of the control group, P〈0.05, the difference was statistically significant. The adverse reactions were compared between the two groups, P〉0.05, and the difference was not statistically significant. Conclusion For patients with unstable angina pectoris, on the basis of conventional medication, trimetazidine dihydrochloride tablets can promote patients to enhance the efficiency of effective treatment.